Ethics in the time of COVID: What remains the same and what is different.

Kim, Scott Y H; Grady, Christine

Kim, Scott Y H; Grady, Christine.

Kim SYH; From the Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, MD. scott.kim@nih.gov.
Grady C; From the Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, MD.

Neurology ; 94(23): 1007-1008, 2020 06 09.

Article in English | MEDLINE | ID: covidwho-38333

Subject(s)

Betacoronavirus; Coronavirus Infections; Ethics, Medical; Pandemics; Pneumonia, Viral; Advance Directives; COVID-19; Comorbidity; Coronavirus Infections/epidemiology; Coronavirus Infections/therapy; Dementia/epidemiology; Disabled Persons; Health Priorities; Health Resources/ethics; Health Resources/supply & distribution; Health Resources/trends; Humans; Neurodegenerative Diseases/epidemiology; Pneumonia, Viral/epidemiology; Pneumonia, Viral/therapy; Practice Guidelines as Topic; Resource Allocation/ethics; Resource Allocation/trends; SARS-CoV-2; Social Stigma; Social Values; Triage/ethics; Triage/trends; Vulnerable Populations

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Ethics, Medical / Pandemics / Betacoronavirus Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Neurology Year: 2020 Document Type: Article Affiliation country: WNL.0000000000009520

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google